CHEST 2026: Day 2 Recap — 4 Headlines to Know

Day 2 of the CHEST 2026 Annual Meeting, held October 18 to 21 in Phoenix, Arizona, brought sessions spanning pulmonary vascular disease, fibrotic interstitial lung disease (ILD), and pulmonary rehabilitation access. Highlights included a review of 3 recent randomized PE trials pointing toward catheter-based intervention in sicker intermediate-risk patients, a practical session on integrating echocardiography with right heart catheterization in pulmonary hypertension, a registry analysis linking short telomeres to Usual Interstitial Pneumonia (UIP) patterning rather than fibrosis burden in ILD, and a debate-based look at new Medicare coverage enabling virtual pulmonary rehabilitation delivery.